| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/24/2008 | US20080096811 Selective vpac2 receptor peptide agonists |
| 04/24/2008 | US20080096810 Cab Molecules |
| 04/24/2008 | US20080096809 Diastereomeric Peptides Useful as Inhibitors of Membrane Protein Assembly |
| 04/24/2008 | US20080096808 co-administering the protein replacement therapy with rapamycin, to inhibiting the immune response of a host to protein replacement therapy; immunology modulators |
| 04/24/2008 | US20080096807 Cyclic vasoactive intestinal peptide receptor-2 agonists |
| 04/24/2008 | US20080096806 Compositions and methods for inhibiting microbial adhesion |
| 04/24/2008 | US20080096805 deoxygenated, endotoxin-free and stroma-free transport proteins, incapable of binding with nitric oxide, useful as substitutes for erythrocytes in mammals and for treating disorders where oxygen delivery agents are of benefit |
| 04/24/2008 | US20080096804 contacting metal oxides and metal hydroxides with amino acids in solvents to form a solution comprising a metal hydroxyl amino acetate reaction product; foods; nutraceuticals; beverages; dairy products; drug adjuvants |
| 04/24/2008 | US20080096803 deoxygenated, endotoxin-free and stroma-free transport proteins, incapable of binding with nitric oxide, useful as substitutes for erythrocytes |
| 04/24/2008 | US20080096802 administering peroxisome proliferator-activated receptor agonists (PPAR) and sodium glucose co-transporters (SGLTs) inhibitors for the treatment of diabetes and Syndrome X |
| 04/24/2008 | US20080096801 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 04/24/2008 | US20080096800 Rapid mucosal gel or film insulin compositions |
| 04/24/2008 | US20080096799 Compounds for and methods of treating insulin resistance and inflammation |
| 04/24/2008 | US20080096798 administering a first peptide comprising 10 to 50 amino acid residues and a second protein selected from bone morphogenic proteins, transforming growth, epidermal growth, epithelial cell growth, fibroblast growth, platelet derived growth or insulin-like growth factors, to enhance regeneration of bones |
| 04/24/2008 | US20080096797 Calcium phosphate delivery vehicles for osteoinductive proteins |
| 04/24/2008 | US20080096796 Peptides That Stimulate Cell Survival and Axon Regeneration |
| 04/24/2008 | US20080096795 Novel Antiangiogenic Peptide Agents and Their Therapeutic and Diagnostic Use |
| 04/24/2008 | US20080096794 proteins used for the prevention and/or treatment of tumors, development disorders, autoimmune diseases,allergies and inflammations; foods or nutraceuticals |
| 04/24/2008 | US20080096793 Class III Slrp for the Treatment of Cancer |
| 04/24/2008 | US20080096792 polypeptides used as wound healing agents, tissue regeneration, inhibition of cancer metastesis mediated by extracellular matrix protein including laminin |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080095872 using modified Clostridial toxin having an orphanin targeting moiety, a domain for translocating a light chain across an endosome membrane; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 04/24/2008 | US20080095856 Encapsulated Nanoparticles for Drug Delivery |
| 04/24/2008 | US20080095854 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/24/2008 | US20080095849 Peptide sustained release compositions and uses thereof |
| 04/24/2008 | US20080095848 Pharmaceutical Composition For Topical Use In Form Of Xerogels Or Films And Methods For Production |
| 04/24/2008 | US20080095837 Human growth hormone formulations |
| 04/24/2008 | US20080095836 Glutathione-based delivery system |
| 04/24/2008 | US20080095834 Mitochondriotropic Phospholipid Vesicles |
| 04/24/2008 | US20080095832 Prosaposin as a neurotrophic factor |
| 04/24/2008 | US20080095830 Containing protein for wound healing; dip coating |
| 04/24/2008 | US20080095821 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 04/24/2008 | US20080095819 Antiproliferative agents; connexins; reducing density of astrocytes; increasing density of neurons; hair growth; cosmetic surgery |
| 04/24/2008 | US20080095817 Template having thereon at least one synthetic degradable extracellular matrix layer and one biomolecule releasably associated with layer, biomolecule comprising cell-affecting portion and matrix-binding portion; temporally controlling growth factor signaling and directing activities of associated cells |
| 04/24/2008 | US20080095815 Hollow and Porous Orthopaedic or Dental Implant that Delivers a Biological Agent |
| 04/24/2008 | US20080095810 Nanoparticle systems for release of biologically active molecules formed by chitosan polymer or derivatives, chemically modified with polyethylene glycol and crosslinked with a crosslinking agent; especially useful for pharmaceutical compositions, vaccines and cosmetic formulations; controlled release |
| 04/24/2008 | US20080095806 Composition And Method For Treating Inflammatory Diseases Using Protease Inhibitors |
| 04/24/2008 | US20080095804 Two-step immunization procedure against chlamydia infection |
| 04/24/2008 | US20080095802 Targeted delivery of cytotoxic drugs A) to activated lymphocytes in patients iwth transplanted organs, B) as radiosensitizers to cancer cells in paients undergoing radiation therapy, and C) in vitaminpbinding proteins as drug carriers in the diagnosis and treatment of cancer |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095780 Binding Molecules For Treatment And Detection Of Cancer |
| 04/24/2008 | US20080095773 Polypeptides homologous to vegf and bmp1 |
| 04/24/2008 | US20080095772 Antibodies against human parathyroid hormone related protein |
| 04/24/2008 | US20080095764 Use of genetically-and epigenetically-altered protocadherins in methods of diagnosing, prognosing, and treating cancer |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095761 Using steroid alkaloid cyclopamine to treat and prevent tumor progression in urogenital system |
| 04/24/2008 | US20080095760 Using fibrinolytic metalloproteinase composition to treat and prevent cardiovascular disorders |
| 04/24/2008 | US20080095759 Defense and Counter-Defense Compositions and Methods |
| 04/24/2008 | US20080095758 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 04/24/2008 | US20080095757 Vitamin c compositions |
| 04/24/2008 | US20080095756 De-immunized antibiotic polypeptide for prevention and treatment of microbial infection |
| 04/24/2008 | US20080095755 Methods and compositions for the treatment of cancer |
| 04/24/2008 | US20080095754 Epithelium cell stabilizer component comprising diglycine, triglycine, tetraglycine and/or pentaglycine for use in treatment of dry eye |
| 04/24/2008 | US20080095753 Pharmacological vitreolysis |
| 04/24/2008 | US20080095742 Composition for Treating Virus Infection Disease Comprising Jab1 |
| 04/24/2008 | US20080095741 Using reduced lipoic acid as tool in treatment of pancreatic disorders; antidiabetic agents |
| 04/24/2008 | US20080095740 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 04/24/2008 | US20080095739 Heterocyclic antiviral compounds |
| 04/24/2008 | US20080095732 A dipeptide with a C terminal threonine, a pentapeptide, preferably palmitoyl-lys-thr-thr-lys-ser, a second dipeptide, and a vitamin B3 compound, preferably niacinamide; cosmetics for hair, skin, and nails; improved aging resistance |
| 04/24/2008 | US20080095718 Atomizing a phosphodiesterase inhibitor, receptor agonists of dopamine, melaocortin, or growth hormone-releasing peptide, or an alpha-adrenoceptor antagonist; with a hand-held delivery device; increased bioavailability; side effect reduction |
| 04/24/2008 | US20080095710 Enzyme treatment of foodstuffs for celiac sprue |
| 04/24/2008 | US20080095706 Detecting binding between the peptide probe and any target protein present in the specific state of self-aggregation,to identify or treat diseases associated with conformationally-altered proteins; medical diagnosis; target protein selectedamyloid islet polypeptide precursor protein, insulin, amylin |
| 04/24/2008 | US20080095703 Method For Checking And Controlling The Mammalian Lactic Acid Fermentation Process / Aerobic Glucose Fermentation Metabolic Pathway In Mammalian Organism |
| 04/24/2008 | CA2675500A1 Ophthalmic compositions comprising diglycine |
| 04/24/2008 | CA2672907A1 Pegylated pth as pth receptor modulators and uses thereof |
| 04/24/2008 | CA2667030A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | CA2666934A1 Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor |
| 04/24/2008 | CA2666887A1 Alpha-msh therapies for treatment of autoimmune disease |
| 04/24/2008 | CA2666859A1 Novel method for treating h.pylori infections |
| 04/24/2008 | CA2666843A1 Treatment of age-related macular degeneration and other diseases of the eye |
| 04/24/2008 | CA2666842A1 Il-17c antagonists and methods of using the same |
| 04/24/2008 | CA2666841A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 04/24/2008 | CA2666794A1 Method and pharmacological composition for the diagnosis and treatment of male sub-fertility |
| 04/24/2008 | CA2666714A1 Sequential combination therapy |
| 04/24/2008 | CA2666667A1 Generating an immune response by inducing cd40 and pattern recognition receptors |
| 04/24/2008 | CA2665262A1 Method and compositions for stabilizing prostate specific antigen |
| 04/24/2008 | CA2664828A1 Rspondins as modulators of angiogenesis and vasculogenesis |
| 04/23/2008 | EP1914554A2 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/23/2008 | EP1914312A2 Virulence genes and proteins, and their use |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914305A1 GSK3 polypeptides |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |
| 04/23/2008 | EP1914241A1 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 04/23/2008 | EP1914239A1 Attentuated gram negative bacteria |
| 04/23/2008 | EP1913955A1 Novel method for treating H.pylori infections |
| 04/23/2008 | EP1913954A2 Agents and methods based on the use of the eda domain of fibronectin |
| 04/23/2008 | EP1913953A1 Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension |
| 04/23/2008 | EP1913952A1 Molecular determinants of myeloma bone disease and uses thereof |
| 04/23/2008 | EP1913400A2 Il-32 modulators |
| 04/23/2008 | EP1913397A1 Graded expression of snail as marker of cancer development and dna damage-based diseases |
| 04/23/2008 | EP1913152A2 Identification of compounds modulating the smyd3 transferase for the treatment of cancer |
| 04/23/2008 | EP1913144A1 Molecular variant fibrinogen fusion proteins |
| 04/23/2008 | EP1913142A2 Delta 6 desaturase from thraustochytrid and uses thereof |
| 04/23/2008 | EP1913138A1 Processes for the manufacture of sterilized pancreatin powder |
| 04/23/2008 | EP1913137A1 Serine beta-lactamase-like / d-aia carboxypeptidase-like protein |
| 04/23/2008 | EP1913025A2 Anti-microbial agents that interact with the complement system |
| 04/23/2008 | EP1913023A1 Novel anticoagulant polypeptides and complex |
| 04/23/2008 | EP1913017A1 Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii |
| 04/23/2008 | EP1913016A1 Macrocyclic peptides as hcv ns3 protease inhibitors |
| 04/23/2008 | EP1913015A1 Macrocyclic inhibitors of hepatitis c virus |